Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Colorectal Cancer
Campto (Irinotecan), Now Available In Seven Additional Countries
May 26th, 1997
Rhone-Poulenc Rorer Inc., Antony, France, announced that Campto (irinotecan), a new anticancer agent, is now available in seven additional countries including Austria, Finland, Luxembourg, Portugal, South Africa, Spain, and the United Kingdom. Campto is indicated for the treatment of advanced metastatic colorectal cancer that has failed to respond to standard chemotherapy with 5-fluorouracil (5-FU) and folinic acid. Campto was also recently approved in Egypt. The drug has now been approved in 16 countries and is available in 10, including France (through RPR), Japan (through Yakult Honsha Co. Ltd.), and the United States (through Pharmacia & Upjohn). ...
Source: Cancer Weekly (1997-05-26)
|
